• GemVax & KAEL issued a correction Nov. 2, 2026, extending its largest shareholder’s share-backed borrowing agreement to Dec. 15 from Oct. 31.
• The renewed agreement covers 300,000 shares pledged by Gem & Company, with collateral set at KRW 5 billion.
• Total pledged shares stand at 5,429,489 across 11 contracts, securing borrowings of KRW 44.77 billion.
• Full enforcement would reduce Gem & Company’s stake to 0.01% from 11.95%, potentially changing the largest shareholder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GemVax & KAEL Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261102900726), on November 02, 2026, and is solely responsible for the information contained therein.